Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 29, 2018 16:30 ET | Source: Endocyte, Inc.

Endocyte to Present at Jefferies Healthcare Conference

WEST LAFAYETTE, Ind., May 29, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced...
May 16, 2018 18:05 ET | Source: Endocyte, Inc.

Endocyte Announces Presentation of Phase 2 Data from Investigator-Initiated Prostate Cancer Trial of 177Lu-PSMA-617 at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

– PSA response rates in additional 20 mCRPC patients enrolled at Peter MacCallum Cancer Centre higher than previously reported for first group of 30 patients – – Company to host and webcast...
May 09, 2018 08:01 ET | Source: Endocyte, Inc.

Endocyte Announces The Lancet Oncology Publication of Phase 2 Data From Investigator-Initiated Prostate Cancer Trial of (177)Lu-PSMA-617

-Publication includes analysis of original 30 patients previously presented at 2017 ESMO by Professor Michael Hofman of Peter MacCallum Cancer Centre- -Relative to previously presented...
May 09, 2018 08:01 ET | Source: Endocyte, Inc.

Endocyte Provides First Quarter 2018 Financial Results and Operational Update

-Recently Updated Phase 2 Data on 177Lu-PSMA-617 Published in The Lancet Oncology Favorable to Preliminary Data Presented at 2017 ESMO Congress- -Positive End of Phase 2 FDA Meeting Set...
May 02, 2018 08:01 ET | Source: Endocyte, Inc.

Endocyte Announces First Quarter 2018 Earnings Call

WEST LAFAYETTE, Ind., May 02, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today...
May 01, 2018 16:01 ET | Source: Endocyte, Inc.

Endocyte to Present at Deutsche Bank's 43rd Annual Health Care Conference

WEST LAFAYETTE, Ind., May 01, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced...
April 16, 2018 09:00 ET | Source: Endocyte, Inc.

Endocyte Presents Data from its CAR T Platform at American Association for Cancer Research (AACR) Annual Meeting 2018

WEST LAFAYETTE, Ind., April 16, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced...
March 15, 2018 16:01 ET | Source: Endocyte, Inc.

Endocyte Announces Presentations at American Association for Cancer Research (AACR) Annual Meeting 2018

WEST LAFAYETTE, Ind., March 15, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced...
March 15, 2018 08:01 ET | Source: Endocyte, Inc.

Endocyte Nominates Dawn Svoronos for Election to Its Board of Directors and Announces Other Board Developments

WEST LAFAYETTE, Ind., March 15, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced...
March 05, 2018 16:01 ET | Source: Endocyte, Inc.

Endocyte to Present at the Cowen and Company 38th Annual Health Care Conference

WEST LAFAYETTE, March 05, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment , today announced that...